Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Clinical manifestations and treatment of dysfunctional uterine bleeding

Article Abstract:

Dysfunctional uterine bleeding is common among women during their reproductive years. It may be caused by a variety of disorders, but the most common cause is anovulation. Anovulation, or the absence of ovulation, is more common during the transitional times of puberty and menopause than during other times in a woman's life. During these times, anovulation is usually the result of physiological changes caused by lower estrogen levels. Some women may suffer from chronic anovulatory bleeding. These women have a higher risk of developing endometrial cancer (cancer of the lining of the uterus) if the abnormal bleeding does not stop. Some women suffering from anovulatory bleeding undergo surgery, but most are treated with different types of hormones. Several synthetic progestational drugs have been used successfully to treat this type of bleeding.

Author: DeCherney, Alan H., Bayer, Steven R.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1993
Usage, Hormone therapy, Uterine bleeding, Uterine hemorrhage, Anovulation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Parkinsonian Features: When Are They Parkinson Disease?

Article Abstract:

Clinical signs and the response to levodopa therapy can aid in distinguishing Parkinson disease (PD) from other parkinsonian syndromes. PD and similar syndromes are characterized by progressive muscle tremors, movement disorders, and stiffness. Dementia, multiple system atrophy, antipsychotic-drug reactions, and other conditions can cause parkinsonian tremors and other symptoms. Slowly progressing impairment in movement, a resting muscle tremor or muscle rigidity, and a rapid response to dopamine replacement, suggest the diagnosis of PD. Hallucinations, dementia, or a failure to clearly respond to levodopa therapy, indicate other causes of the parkinsonian symptoms.

Author: Litvan, Irene
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Diagnosis, Tremor, Parkinson's disease, Parkinson disease, Akinesia, Parkinsonism, Symptomatic, Secondary Parkinson disease

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Clinical Features and Treatment of Peristomal Pyoderma Gangrenosum

Article Abstract:

Pyoderma gangrenosum that occurs around an ostomy opening may be difficult to treat, according to a study of 7 patients. Five had a relapse after the initial healing and moving the ostomy only caused the disease to recur at the new site. Pyoderma gangrenosum is an inflammation of the skin that causes ulcers.

Author: Hughes, Amy P., Jackson, J. Mark, Callen, Jeffrey P.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
Pyoderma

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment
Similar abstracts:
  • Abstracts: Clinical course and outcome of substance abuse disorders in adolescents. Testosterone abuse and affective disorders
  • Abstracts: A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Lyme disease agent borrows a practical coat
  • Abstracts: Electronic fetal heart monitoring, auscultation, and neonatal outcome. Fetal heart rate monitoring: is it salvageable?
  • Abstracts: Promoting Early Diagnosis and Treatment of Type 2 Diabetes: The National Diabetes Education Program. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus
  • Abstracts: Acute maternal rehydration increases the urine production rate in the near-term human fetus. Initial development of a system-wide maternal-fetal outcomes assessment program
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.